Human gastrointestinal helminth infections: Are they now neglected diseases?

Trends in Parasitology

Volumn 19, Issue 11, 2003, Pages 527-531

  Horton, John ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; LEVAMISOLE; MEBENDAZOLE; NITAZOXANIDE; PIPERAZINE; PRAZIQUANTEL; PYRANTEL;

CONTROLLED STUDY; DRUG EFFICACY; GASTROINTESTINAL INFECTION; HELMINTHIASIS; HUMAN; MOLECULAR RECOGNITION; REVIEW;

NEMATODA; VERMES;

EID: 0142227139     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2003.09.007     Document Type: Review

References (54)

1. Crompton D.W.T. How much human helminthiasis is there in the world? J. Parasitol. 85:1999;397-403.
2. Stoll N.R. This Wormy World. J. Parasitol. 33:1947;1-18.
3. Stephenson L.S., et al. Weight gain of Kenyan school children infected with hookworm, Trichuris trichiura and Ascaris is improved following once or twice yearly treatment with albendazole. J. Nutr. 123:1993;656-665.
4. Hadju V., et al. Improvements in appetite and growth in helminth infected schoolboys three and seven weeks after a single dose of pyrantel pamoate. Parasitology. 113:1996;497-504.
5. Stephenson L.S., et al. Physical fitness, growth and appetite of Kenyan schoolboys with hookworm, Trichuris trichiura and Ascaris lumbricoides infection are improved four months after a single dose of albendazole. J. Nutr. 123:1993;1036-1046.
6. Simeon D.T., et al. Treatment of Trichuris trichiura infections improves growth, spelling scores and school attendance in some children. J. Nutr. 125:1995;1875-1883.
7. Dossa R.A., et al. Impact of iron supplementation and deworming on growth performance in preschool Beninese children. Eur. J. Clin. Nutr. 55:2001;223-228.
8. Gilgen D.D., et al. Intestinal helminth infections, anaemia and labour productivity of female tea pluckers in Bangladesh. Trop. Med. Int. Health. 6:2001;449-457.
9. Torlesse H., Hodges M. Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone). Trans. R. Soc. Trop. Med. Hyg. 95:2001;195-201.
10. WHA (2001) Schistosomiasis soil-transmitted helminth infections. Fifty-fourth World Health Assembly, resolution WHA54.19.
11. Bench Aids for the Diagnosis of Intestinal Parasites. 1994;World Health Organization, Geneva.
12. Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 18:1988;885-936.
13. Lacey E., et al. Comparison of inhibition of polymerisation of mammalian tubulin and helminth ovicidal activity by benzimidazole carbamates. Vet. Parasitol. 23:1987;105-119.
14. Boes J., et al. Embryonation and infectivity of Ascaris suum eggs isolated from worms expelled by pigs treated with albendazole, pyrantel pamoate, ivermectin or piperazine dihydrochloride. Vet. Parasitol. 75:1998;181-190.
15. Maisonneuve H., et al. Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis. Ann. Trop. Med. Parasitol. 79:1985;79-82.
16. Cline B.L., et al. Larvicidal activity of albendazole against Necator americanus in human volunteers. Am. J. Trop. Med. Hyg. 33:1984;387-394.
17. Marti H., et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am. J. Trop. Med. Hyg. 55:1996;477-481.
18. el-Morshedy H.R., et al. Triclabendazole in the treatment of human fascioliasis: a community-based study. East. Mediterr. Health J. 5:1999;888-894.
19. Fetterer R., et al. Comparative efficacy of albendazole against Fasciola hepatica in sheep and calves: relationship to serum drug metabolite levels. Vet. Parasitol. 11:1982;309-316.
20. Warren K.S. The present impossibility of eradicating the omnipresent worm. Rev. Infect. Dis. 4:1982;955-965.
21. Schad G., Anderson R.M. Predisposition to hookworm infection in humans. Science. 228:1985;1537-1540.
22. Horton J. Albendazole: a review of anthelminthic efficacy and safety in humans. Parasitology. 121(Suppl):2000;S113-S122.
23. Drake L.J., Bundy D.A. Multiple helminth infections in children: impact and control. Parasitology. 122(Suppl):2001;S73-S81.
24. Stephenson L.S. Optimising the benefits of anthelmintic treatment in children. Paediatr. Drugs. 3:2001;495-508.
25. Stoltzfus R.J., et al. Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. BMJ. 323:2001;1389-1393.
26. Garrow S.C., et al. Hookworm control programs and anaemia. Med. J. Aust. 175:2001;442-443.
27. Taylor M., et al. The effect of different anthelmintic treatment regimens combined with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial. Trans. R. Soc. Trop. Med. Hyg. 95:2001;211-216.
28. Del Brutto O.H., et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 57:2001;177-183.
29. Flisser A. Neurocysticercosis and epilepsy in developing countries. J. Neurol. Neurosurg. Psychiatry. 70:2001;707-708.
30. Eckert J., et al. Echinococcosis: an emerging or re-emerging zoonosis? Int. J. Parasitol. 30:2000;1283-1294.
31. Garcia H.H., et al. Current consensus guidelines for treatment of neurocysticercosis. Clin. Microbiol. Rev. 15:2002;747-756.
32. Sotelo J., et al. Albendazole vs. praziquantel for therapy for neurocysticercosis: a controlled trial. Arch. Neurol. 45:1988;532-534.
33. Cruz M., et al. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans. R. Soc. Trop. Med. Hyg. 85:1991;244-247.
34. Del Brutto O.H., et al. Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology. 52:1999;1079-1081.
35. Horton R.J. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop. 64:1997;79-93.
36. Rigano R., et al. Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates. Clin. Exp. Immunol. 129:2002;485-492.
37. Harinasuta T., et al. Efficacy of praziquantel on fasciolopsiasis. Arzneimittelfors. 34:1984;1214-1215.
38. Horton J. Albendazole in the treatment of 'imported' diseases. Visser L.G., et al. Importziekten. 2000;137-155 Boerhave Commissie.
39. Sacko M., et al. Comparison of the efficacy of mebendazole, albendazole and pyrantel in the treatment of human hookworm infections in the southern region of Mali. Trans. R. Soc. Trop. Med. Hyg. 93:1999;195-203.
40. Reynoldson J.A., et al. Failure of pyrantel in the treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. Acta Trop. 68:1997;301-312.
41. Rossignol J.F., Maisonneuve H. Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections. Am. J. Trop. Med. Hyg. 33:1984;511-512.
42. Juan J.O., et al. Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. Trans. R. Soc. Trop. Med. Hyg. 96:2002;193-196.
43. Davila-Gutierrez C.E., et al. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am. J. Trop. Med. Hyg. 66:2002;251-254.
44. Cedillo-Rivera R., et al. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. J. Eukaryot. Microbiol. 49:2002;201-208.
45. Theodorides V.J., et al. Efficacy of oxibendazole against gastrointestinal nematodes of cattle. Am. J. Vet. Res. 37:1976;1207-1209.
46. Huang Y.X., et al. [Clinical observations on the treatment of hookworm, Ascaris and Trichuris infection with oxibendazole.] (in Chinese). Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 8:1990;100-103.
47. Theodorides V.J., et al. Toxicologic and teratologic studies of oxibendazole in ruminants and laboratory animals. Am. J. Vet. Res. 38:1977;809-814.
48. Beach M.J., et al. Assessment of combined ivermectin and albendazole treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. Am. J. Trop. Med. Hyg. 60:1999;479-486.
49. Belizario V.Y., et al. A comparison of the efficacy of single doses of albendazole, ivermectin and diethylcarbamazine alone or in combination against Ascaris and Trichuris spp. Bull. World Health Organ. 81:2003;35-42.
50. Moxidectin shows potential for use in human onchocerciasis and filariasis. TDR News. 62:2000;11.
51. Dissanaike A.S. A comparative trial of oxantel-pyrantel and mebendazole in multiple helminth infection in school children. Drugs. 15:(Suppl.):1978;73- 77.
52. Lee S.Y., Lim J.K. A comparative study of the effect of oxantel-pyrantel suspension and mebendazole in mixed infections with Ascaris and Trichuris. Drugs. 15:(Suppl. 1):1978;94-98.
53. Albonico M., et al. Evaluation of the efficacy of pyrantel-oxantel for the treatment of soil-transmitted nematode infections. Trans. R. Soc. Trop. Med. Hyg. 96:2002;685-690.
54. Couper M.R., Mehta D.K. WHO Model Formulary. 2002;71-91 World Health Organization.